ReNu MultiPlus is safe, Bausch & Lomb Korea says

Published: 2006-06-15 06:56:00

Updated: 2006-06-15 06:56:00

After Bausch & Lomb Inc. decided to recall its ReNu with MoistureLoc contact lens solution in the U.S. market, which has been linked to dozens of cases of a serious eye infection, ReNu MultiPlus is gradually restoring confidence from customers, according to officials form Bausch & Lomb Korea.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK